Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,922.51
+817.69(+1.63%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

BIO-key International, Inc. (BKYI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

1.7000

+0.0300

(+1.80%)

At close: 04:00PM EDT

1.6100

-0.09

(-5.29%)

After hours:

06:12PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	3.08M
Enterprise value	5.51M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.10
Price/book (mrq)	0.93
Enterprise value/revenue	0.64
Enterprise value/EBITDA	-0.66

Trading information

Stock price history

Beta (5Y monthly)	0.43
52-week change ³	-85.99%
S&P500 52-week change ³	22.38%
52-week high ³	15.3000
52-week low ³	1.4800
50-day moving average ³	1.8992
200-day moving average ³	5.0292

Share statistics

Avg vol (3-month) ³	54.48k
Avg vol (10-day) ³	13.87k
Shares outstanding ⁵	1.81M
Implied shares outstanding ⁶	1.81M
Float ⁸	622.85k
% held by insiders ¹	4.93%
% held by institutions ¹	5.47%
Shares short (15 Apr 2024) ⁴	8.74k
Short ratio (15 Apr 2024) ⁴	0.35
Short % of float (15 Apr 2024) ⁴	0.51%
Short % of shares outstanding (15 Apr 2024) ⁴	0.48%
Shares short (prior month 15 Mar 2024) ⁴	20.51k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	20 Nov 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:18
Last split date ³	21 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	-106.40%
Operating margin (ttm)	-42.13%

Management effectiveness

Return on assets (ttm)	-27.30%
Return on equity (ttm)	-125.93%

Income statement

Revenue (ttm)	8.59M
Revenue per share (ttm)	17.48
Quarterly revenue growth (yoy)	32.30%
Gross profit (ttm)	N/A
EBITDA	-5.06M
Net income avi to common (ttm)	-9.14M
Diluted EPS (ttm)	-19.6200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	307.09k
Total cash per share (mrq)	0.4
Total debt (mrq)	2.74M
Total debt/equity (mrq)	82.67%
Current ratio (mrq)	1.30
Book value per share (mrq)	6.28

Cash flow statement

Operating cash flow (ttm)	-4.16M
Levered free cash flow (ttm)	-1.31M